Asset Team Lead (ATL), Skeletal Conditions Business Unit

Role: Asset Team Lead for BioMarin's Skeletal Conditions Business Unit, responsible for leading the integrated development and strategic alignment of a high-value asset across its lifecycle, from development through commercialization. Responsibilities include shaping asset strategy, fostering cross-functional collaboration (including Medical, Clinical, Regulatory, Commercial, and Market Access), driving decision-making through governance forums, and ensuring timely achievement of milestones while maximizing long-term value. The role demands influence-driven leadership in a highly matrixed environment, guiding teams without direct authority. Requirements: over 10 years in biotech/pharma, with 5+ years leading complex cross-functional initiatives, proven strategic thinking, and influencing skills. Preferred: experience in product development, commercialization, or portfolio strategy, with a deep understanding of the biopharmaceutical product lifecycle. High-value specifics include a focus on rare diseases, genetic conditions, biologics or small molecules, with an emphasis on enterprise leadership, decision-making excellence, and stakeholder engagement. The position entails strategic planning, cross-functional team leadership, and critical decision-making to accelerate asset value and patient impact.